You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MDV3100

Showing 1 - 25 of 88
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial (ADT, Enzalutamide, Talazoparib)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
May 15, 2023

Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)

Active, not recruiting
  • Prostate Cancer
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 4, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Portland, Seattle

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Portland, Oregon
  • +2 more
Jun 24, 2022

mCRPC Trial in San Francisco, Portland (ZEN003694, Enzalutamide)

Enrolling by invitation
  • mCRPC
  • San Francisco, California
  • +1 more
May 31, 2022

Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 26, 2022

Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)

Active, not recruiting
  • Prostate Cancer
  • Los Angeles, California
    University of California, Los Angeles
Aug 25, 2022

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United

Recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Feb 2, 2023

Metastatic Castration Resistant Prostate Cancer Trial in India (Enzalutamide, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Ahmedabad, India
  • +7 more
Jan 21, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
  • +1 more
Sep 20, 2022

Prostate Cancer Trial in Boston (Tivozanib, Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Castration-resistant Prostate Cancer Trial in Boston (Crizotinib, Enzalutamide)

Completed
  • Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 5, 2022

Breast Cancer Trial in Aurora, New York, Germantown (Enzalutamide, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +2 more
Feb 22, 2022

Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 27, 2022

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer Trial in New Brunswick (drug, other, procedure)

Terminated
  • Clear Cell Renal Cell Carcinoma
  • Stage I Renal Cell Cancer
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 14, 2021

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Scottsdale, Jacksonville, Rochester

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Stage IVB Prostate Cancer AJCC v8
  • Biopsy
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Feb 15, 2023

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Birmingham, Detroit, Columbus

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +2 more
  • Birmingham, Alabama
  • +3 more
Mar 2, 2021

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Pancreatic Cancer Trial in Tampa (Enzalutamide, Gemcitabine, Nab-paclitaxel)

Completed
  • Pancreatic Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 16, 2021

Prostate Adenocarcinoma Trial in Washington (Entinostat, Enzalutamide)

Terminated
  • Prostate Adenocarcinoma
  • Washington, District of Columbia
    George Washington University - Medical Faculty Associates
Jul 26, 2021

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta

Not yet recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +2 more
  • Atlanta, Georgia
  • +1 more
Feb 8, 2023

Breast Cancer Trial in Aurora, Lone Tree, Germantown (Fulvestrant with Enzalutamide)

Completed
Has Results
  • Breast Cancer
  • Fulvestrant with Enzalutamide
  • Aurora, Colorado
  • +2 more
Apr 23, 2021

Ann Arbor Stage I Mantle Cell Lymphoma, Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma Trial

Terminated
Has Results
  • Ann Arbor Stage I Mantle Cell Lymphoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 16, 2021

Metastatic Hormone Sensitive Prostate Cancer Trial in China (Enzalutamide, Placebo, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Metastatic Hormone Sensitive Prostate Cancer
  • Beijing, China
  • +29 more
Jan 7, 2023

Metastatic Castration-Resistant Prostate Cancer Trial in United States (ZEN003694, Enzalutamide)

Completed
Has Results
  • Metastatic Castration-Resistant Prostate Cancer
  • Los Angeles, California
  • +7 more
Nov 2, 2021